Skip to main content

Abstract

This chapter, more than any other, is written for nonmedical professionals and parents to introduce them to what may at first seem a dauntingly arcane field and to empower them to seek good information. It sets the scene for all the other chapters by introducing some basic terminology and concepts, most of which are familiar to prescribers. However, hopefully even they will benefit from a quick overview and reminder of things they know.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Bradley C: The behavior of children receiving Benzedrine. Am J Orthopsychiatry 9:577–585, 1937.

    Google Scholar 

  2. Conners CK: Pharmacotherapy, in Quay HC, Werry JS (eds): Psychopathological Disorders of Childhood. New York, John Wiley & Sons, 1972, pp 316–347.

    Google Scholar 

  3. Sprague RL, Werry JS: Methodology of psychopharmacological studies in the retarded, in Ellis N (ed): International Review of Mental Retardation. New York, Academic Press, 1971, vol 5, pp 147–219.

    Google Scholar 

  4. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, ed 3. Washington, DC, American Psychiatric Association, 1980.

    Google Scholar 

  5. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, ed 4. Washington, DC, American Psychiatric Association, 1994.

    Google Scholar 

  6. Aman MG, Singh NN: Psychopharmacology of the Developmental Disabilities. Berlin, Springer, 1988.

    Book  Google Scholar 

  7. Lehmann HE: Strategies in clinical psychopharmacology, in Lipton MA, Di Mascio A, Killam KF (eds): Psychopharmacology: A Generation of Progress. New York, Raven Press, 1978, p 13.

    Google Scholar 

  8. Werry JS: Child and adolescent schizophrenia: A review in the light of DSM-III-R. J Autism Dev Disord 22:601–624, 1992.

    Article  PubMed  Google Scholar 

  9. Weiss G, Hechtman LT: Hyperactive Children Grown Up. New York, Guilford Press, 1986, pp 240–256.

    Google Scholar 

  10. Efron DH: Psychopharmacology: A Review of Progress1957–1967. New York, Raven Press, 1968.

    Google Scholar 

  11. Werry JS, Carlielle J: The nuclear family, suburban neurosis and iatrogenesis in mothers of preschool children. J Am Acad Child Psychiatry 22:172–179, 1983

    Article  PubMed  Google Scholar 

  12. Sulzbacher S: Psychotropic medication with children: An evaluation of procedural biases in results of reported studies. Pediatrics 51:513–517, 1973.

    PubMed  Google Scholar 

  13. Schoonover SC: Introduction: The practice of pharmacotherapy, in Bassuk EL, Schoonover SC, Gelenberg AJ (eds): The Practitioner’s Guide to Psychoactive Drugs, ed 2. New York, Plenum Press, 1988, pp 1–18.

    Google Scholar 

  14. Kane JM: Treatment of schizophrenia. Schizophr Bull 13:147–170, 1987.

    Article  Google Scholar 

  15. Feagens L: A current view of learning disabilities. J Pediatr 102:487–493, 1983.

    Article  Google Scholar 

  16. Sprague RL, Sleator E: Methylphenidate in hyperactive children: Differences in dose effects on learning and social behavior. Science 198:1274–1276, 1977.

    Article  PubMed  Google Scholar 

  17. Wilens TE, Spencer T, Biederman J, Wosniak J, Connor D: Combined pharmacotherapy: An emerging trend in pediatric psychopharmacology. J Am Acad Child Adolesc Psychiatry 34:110–112, 1995.

    Article  PubMed  Google Scholar 

  18. Ciraulo DA, Shader RI, Greenblatt DJ, Creelman W: Drug Interactions in Psychiatry, ed 2. Baltimore, Williams and Wilkins, 1995.

    Google Scholar 

  19. Fenichel RR: Combining methylphenidate and Clonidine: The role of post-marketing surveillance. J Child Adolesc Psychopharmacol 5:155–156, 1995.

    Article  Google Scholar 

  20. Stine JJ: Psychosocial and psychodynamic issues affecting noncompliance with psychostimulant treatment. J Child Adolesc Psychopharmacol 4:75–86, 1994

    Article  Google Scholar 

  21. Bastiaens L: Knowledge, attitudes and compliance with pharmacotherapy in adolescent patients and their parents. J Child Adolesc Psychopharmacol 5:39–48, 1995.

    Article  Google Scholar 

  22. Wilson LJ, Jennings JN: Parents’ acceptability of alternative treatments for Attention-Deficit Hyperactivity Disorder. J Attention Disord, 1:114–121, 1996.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1999 Springer Science+Business Media New York

About this chapter

Cite this chapter

Werry, J.S. (1999). Introduction: A Guide for Practitioners, Professionals, and Public. In: Werry, J.S., Aman, M.G. (eds) Practitioner’s Guide to Psychoactive Drugs for Children and Adolescents. Springer, Boston, MA. https://doi.org/10.1007/978-1-4899-0086-9_1

Download citation

  • DOI: https://doi.org/10.1007/978-1-4899-0086-9_1

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-0-306-45885-9

  • Online ISBN: 978-1-4899-0086-9

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics